Eric Topol 援引 NEJM 发表的黑色素瘤治疗性疫苗成功结果及其社论指出,针对 KRAS、BRAF、PIK3CA 等基因 25 个复发突变热点的疫苗,可覆盖结直肠癌、胰腺癌、子宫癌和黑色素瘤皮肤癌中超过 70% 的突变。Moderna 表示这是未来方向,正在开展预防 Lynch 综合征的试验,并将推进更多项目。
借NEJM黑色素瘤治疗性疫苗发表与社论观点,呈现疫苗用于癌症预防的潜在覆盖范围。
Moving on to preventing cancer with vaccines
With today's @NEJM publication of the melanoma treatment vaccine success https://www.nejm.org/doi/full/10.1056/NEJMoa2609762?query=featured_home
The editorial notes the remarkable potential for vaccines to prevent cancer:
https://www.nejm.org/doi/full/10.1056/NEJMoa2609762?query=featured_home
"a vaccine against 25 recurrent mutational hotspots
in genes such as KRAS, BRAF, and PIK3CA could
target mutations found in more than 70% of
colorectal, pancreatic, uterine, and melanoma
skin cancers."
And @moderna_tx declares it's the future with an ongoing trial to prevent Lynch syndrome and more to come
https://www.ft.com/content/30b27a58-35bf-4156-ab1a-0a8812b68f4e?syn-25a6b1a6=1&shem=aimgspe,
来源:Eric Topol · x.com